Thomas Emil Andersen

Medicine & Life Sciences

1. Uropathogenic Escherichia coli 100%
2. Urinary Tract Infections 58%
3. Swine 54%
4. Urinary Bladder 37%
5. SARS Virus 28%
6. Cystitis 27%
7. Leucine-2-Alanine Enkephalin 26%
8. Infections 26%
9. Bacteria 25%
10. Catheters 24%
11. Urine 22%
12. Severe Acute Respiratory Syndrome 22%
13. Coronavirus 21%
14. Opioid Peptides 21%
15. Escherichia coli 20%
16. Dicloxacillin 19%
17. Prodrugs 19%
18. Biofilms 19%
19. Staphylococcal Infections 18%
20. Thioridazine 16%
21. Integrated Delivery of Health Care 16%
22. Staphylococcus aureus 15%
23. Growth 15%
24. Polymers 15%
25. Urinary Tract 15%
26. Complement Activation 14%
27. Urinary Catheters 14%
28. Genome 14%
29. In Vitro Techniques 14%
30. Vaccines 13%
31. tyrosyl-alanyl-glycyl-phenylalanine 13%
32. Equipment and Supplies 13%
33. Virulence 12%
34. Immunocompromised Host 12%
35. Genes 12%
36. Intestinal Mucosa 12%
37. Drug Delivery Systems 11%
38. Silicones 11%
39. plectasin 11%
40. valspodar 11%
41. 2-hydroxypyridine 10%
42. Statistical Factor Analysis 10%
43. Vaccination 10%
44. ATP Binding Cassette Transporter, Subfamily B, Member 1 10%
45. Anti-Bacterial Agents 9%
46. Amdinocillin 9%
47. Escherichia coli Infections 9%
48. Silicone Elastomers 9%
49. Pyrrolidinones 8%
50. Complement Inactivating Agents 8%